U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 182

Tests names and labsConditionsGenes, analytes, and microbesMethods

NGS Oncology Melanoma Profile (Tissue Only)

Diagnostic Laboratory Services, Inc.
United States
141
  • C Sequence analysis of the entire coding region

Guardant360 TissueNext

Guardant Health
United States
185
  • M Methylation analysis
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Guardant360 Response

Guardant Health
United States
174
  • E Sequence analysis of select exons
  • T Targeted variant analysis

NeXT Dx

Personalis, Inc.
United States
1413
  • I Microsatellite instability testing (MSI)
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Guardant360

Guardant Health
United States
184
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Tempus xT

Tempus AI - RTP
United States
2647
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Plus Panel

BioReference Health
United States
9777
  • C Sequence analysis of the entire coding region

Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
10999
  • X Mutation scanning of select exons

EGFR Gene Nonsmall cell lung cancer, familial, susceptibility to NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

EGFR Gene EGFR, selective sequencing of exons 18-21 NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

Hereditary Expanded Cancer Panel

Mayo Clinic Laboratories Mayo Clinic
United States
186
  • C Sequence analysis of the entire coding region

NGS Oncology Tumor Profile

Diagnostic Laboratory Services, Inc.
United States
540
  • C Sequence analysis of the entire coding region

FoundationOne CDx

Foundation Medicine, Inc.
United States
11
  • D Deletion/duplication analysis
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Lung Cancer Driver Profile

GoPath Diagnostics
United States
13
  • I Immunohistochemistry
  • F Fluorescence in situ hybridization (FISH)
  • D Deletion/duplication analysis

Tempus xT

Tempus AI - CHI
United States
2647
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

FoundationOne® Heme

Foundation Medicine, Inc.
United States
2405
  • D Deletion/duplication analysis
  • R RNA analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

EGFR targeted variants

CIBIC S.A.
Argentina
21
  • T Targeted variant analysis

Tempus xF

Tempus AI - RTP
United States
1105
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

Myeloid Next Generation Sequencing with Reflex Pathology Interp

Sentara Healthcare Laboratory Services
United States
369
  • T Targeted variant analysis

NEXT GEN SEQUENCING COMPREHENSIVE SOLID TUMOR PANEL

Alverno Laboratories
United States
127
  • T Targeted variant analysis

Results: 1 to 20 of 182

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.